Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions
| Autor: | Cinzia Cosini, Francesca Spina, Caterina Congregati, Stefania Tommasi, Mariella Tancredi, Rosa Scarpitta, Enrico Tagliafico, Francesca Bellè, Tiziana Cervelli, Luisa Balestrino, Elisabetta Falaschi, Maria Grazia Tibiletti, Gaetana Gambino, Alvaro Galli, Eleonora Conti, Elena Tenedini, Marco Marino, Paolo Aretini, Ileana Carnevali, Matteo Ghilli, Caterina Vivanet, Chiara Guglielmi, Laura Cortesi, Brunella Pilato, Margherita Patruno, Maria A. Caligo |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Proband Gene panel Genes BRCA2 Genes BRCA1 Penetrance Regulatory Sequences Nucleic Acid Coding variants Cohort Studies 0302 clinical medicine BRCA1/2 Breast cancer predisposition genes Hereditary breast and ovarian cancer NGS Non‐coding variants Regulatory regions Adult Age of Onset Female Genetic Predisposition to Disease Genetic Variation Germ-Line Mutation Hereditary Breast and Ovarian Cancer Syndrome Humans Italy Middle Aged PTEN Phosphohydrolase Biology (General) Spectroscopy Genetics General Medicine Computer Science Applications Chemistry 030220 oncology & carcinogenesis QH301-705.5 PALB2 Biology Article Catalysis Inorganic Chemistry 03 medical and health sciences Breast cancer Germline mutation medicine PTEN Physical and Theoretical Chemistry QD1-999 Molecular Biology CHEK2 Nucleic Acid Organic Chemistry BRCA1 medicine.disease BRCA2 030104 developmental biology Genes non-coding variants biology.protein Age of onset Regulatory Sequences |
| Zdroj: | International Journal of Molecular Sciences, Vol 22, Iss 7693, p 7693 (2021) International Journal of Molecular Sciences Volume 22 Issue 14 |
| ISSN: | 1422-0067 |
| Popis: | With the progress of sequencing technologies, an ever-increasing number of variants of unknown functional and clinical significance (VUS) have been identified in both coding and non-coding regions of the main Breast Cancer (BC) predisposition genes. The aim of this study is to identify a mutational profile of coding and intron-exon junction regions of 12 moderate penetrance genes (ATM, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53) in a cohort of 450 Italian patients with Hereditary Breast/Ovarian Cancer Syndrome, wild type for germline mutation in BRCA1/2 genes. The analysis was extended to 5′UTR and 3′UTR of all the genes listed above and to the BRCA1 and BRCA2 known regulatory regions in a subset of 120 patients. The screening was performed through NGS target resequencing on the Illumina platform MiSeq. 8.7% of the patients analyzed is carriers of class 5/4 coding variants in the ATM (3.6%), BRIP1 (1.6%), CHEK2 (1.8%), PALB2 (0.7%), RAD51C (0.4%), RAD51D (0.4%), and TP53 (0.2%) genes, while variants of uncertain pathological significance (VUSs)/class 3 were identified in 9.1% of the samples. In intron-exon junctions and in regulatory regions, variants were detected respectively in 5.1% and in 32.5% of the cases analyzed. The average age of disease onset of 44.4 in non-coding variant carriers is absolutely similar to the average age of disease onset in coding variant carriers for each proband’s group with the same cancer type. Furthermore, there is not a statistically significant difference in the proportion of cases with a tumor onset under age of 40 between the two groups, but the presence of multiple non-coding variants in the same patient may affect the aggressiveness of the tumor and it is worth underlining that 25% of patients with an aggressive tumor are carriers of a PTEN 3′UTR-variant. This data provides initial information on how important it might be to extend mutational screening to the regulatory regions in clinical practice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|